Carregant...
Next generation therapeutics for inflammatory bowel disease
Tumor necrosis factor (TNF)-antagonists are the cornerstone of therapy for moderately-severely active inflammatory bowel disease (IBD). Although our understanding of pharmacokinetics, pharmacodynamics, and treatment optimization for these agents has evolved considerably over the past decade, a subst...
Guardat en:
| Publicat a: | Curr Gastroenterol Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5901649/ https://ncbi.nlm.nih.gov/pubmed/27461274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11894-016-0522-0 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|